Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 357 publications
Treatment of transplant-ineligible newly diagnosed multiple myeloma: advances and future outlook
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Comparative efficacy of anti-CD38 monoclonal antibodies in multiple myeloma using a network meta-analysis.
Journal: British journal of haematology
Published: August 19, 2025
Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 08, 2025
Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 07, 2025
Two Immediate Hypersensitivity Reactions to Isatuximab Confirmed by the Complement Activation Test and Treated With Successful Rapid Desensitization.
Journal: Journal of investigational allergology & clinical immunology
Published: July 28, 2025
Two Immediate Hypersensitivity Reactions to Isatuximab Confirmed by the Complement Activation Test and Treated With Successful Rapid Desensitization.
Journal: Journal of investigational allergology & clinical immunology
Published: July 28, 2025
Plain language summary on subcutaneous administration of isatuximab in people with relapsed and/or refractory multiple myeloma.
Journal: Future oncology (London, England)
Published: July 17, 2025
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions.
Journal: Expert opinion on investigational drugs
Published: July 14, 2025
A Rare Case of Pseudohypercalcemia Associated with Multiple Myeloma.
Journal: The Kobe journal of medical sciences
Published: July 03, 2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group.
Journal: Clinical hematology international
Published: June 27, 2025
Multicenter evaluation of soluble CD38: neutralizing anti-CD38 pan-reactivity to enable alloantibody detection.
Journal: Blood transfusion = Trasfusione del sangue
Published: June 19, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024.
Journal: Transplantation and cellular therapy
Published: June 16, 2025
Last Updated: 10/31/2025